|
2025-03-25 |
2025-03-24 |
GV
Geplanter Verkauf
|
Sacco Tracey
Chief Commercial Officer
Führungsperson
|
5.000
-6.5%
32,89
164.459 USD
|
5.000
-6.5%
|
32,89
|
164.459 USD
|
|
|
2025-03-25 |
2025-03-24 |
GV
Geplanter Verkauf
|
Sacco Tracey
Chief Commercial Officer
Führungsperson
|
1.500
-1.9%
33,70
50.556 USD
|
1.500
-1.9%
|
33,70
|
50.556 USD
|
|
|
2025-03-25 |
2025-03-24 |
GV
Geplanter Verkauf
|
Moore Erin
Interim PFO and PAO
Führungsperson
|
13.564
-14.1%
33,12
449.237 USD
|
13.564
-14.1%
|
33,12
|
449.237 USD
|
|
|
2025-03-19 |
2025-03-17 |
GV
Geplanter Verkauf
|
Peng Katie
Nicht geschäftsführender Verwaltungsratsmitglied
|
1.006
-3.2%
34,42
34.627 USD
|
1.006
-3.2%
|
34,42
|
34.627 USD
|
|
|
2025-03-12 |
2025-03-10 |
GV
Geplanter Verkauf
|
Myles Edward H
COO & CFO
Führungsperson
|
29.395
-20.9%
34,87
1.025.004 USD
|
29.395
-20.9%
|
34,87
|
1.025.004 USD
|
|
|
2025-03-12 |
2025-03-10 |
GV
Geplanter Verkauf
|
Myles Edward H
COO & CFO
Führungsperson
|
112.897
-44.5%
35,82
4.043.971 USD
|
112.897
-44.5%
|
35,82
|
4.043.971 USD
|
|
|
2025-02-20 |
2025-02-19 |
GV
Geplanter Verkauf
|
Qatanani Mo
CHIEF SCIENTIFIC OFFICER
Führungsperson
|
20.202
-15.4%
37,74
762.498 USD
|
20.202
-15.4%
|
37,74
|
762.498 USD
|
|
|
2025-02-20 |
2025-02-19 |
GV
Geplanter Verkauf
|
Qatanani Mo
CHIEF SCIENTIFIC OFFICER
Führungsperson
|
8.341
-6.0%
37,56
313.289 USD
|
8.341
-6.0%
|
37,56
|
313.289 USD
|
|
|
2025-02-20 |
2025-02-19 |
GV
Geplanter Verkauf
|
Qatanani Mo
CHIEF SCIENTIFIC OFFICER
Führungsperson
|
39.967
-22.3%
37,20
1.486.692 USD
|
39.967
-22.3%
|
37,20
|
1.486.692 USD
|
|
|
2025-02-20 |
2025-02-18 |
V
Verkauf
|
Qatanani Mo
CHIEF SCIENTIFIC OFFICER
Führungsperson
|
4.135
-3.1%
36,83
152.288 USD
|
4.135
-3.1%
|
36,83
|
152.288 USD
|
|
|
2025-02-20 |
2025-02-18 |
V
Verkauf
|
Parlavecchio Caryn
CHRO
Führungsperson
|
5.296
-3.6%
36,83
195.046 USD
|
5.296
-3.6%
|
36,83
|
195.046 USD
|
|
|
2025-02-20 |
2025-02-18 |
V
Verkauf
|
Myles Edward H
COO & CFO
Führungsperson
|
7.809
-5.3%
36,83
287.598 USD
|
7.809
-5.3%
|
36,83
|
287.598 USD
|
|
|
2025-02-20 |
2025-02-18 |
V
Verkauf
|
Ho Junlin
GENERAL COUNSEL
Führungsperson
|
5.742
-2.9%
36,83
211.472 USD
|
5.742
-2.9%
|
36,83
|
211.472 USD
|
|
|
2025-02-20 |
2025-02-18 |
V
Verkauf
|
Backstrom Jay T.
CHIEF EXECUTIVE OFFICER
Geschäftsführender Verwaltungsratsmitglied
|
18.372
-5.6%
36,83
676.622 USD
|
18.372
-5.6%
|
36,83
|
676.622 USD
|
|
|
2025-01-21 |
2025-01-16 |
V
Verkauf
|
Ho Junlin
GENERAL COUNSEL
Führungsperson
|
9.039
-4.4%
44,20
399.498 USD
|
9.039
-4.4%
|
44,20
|
399.498 USD
|
|
|
2025-01-21 |
2025-01-16 |
V
Verkauf
|
Qatanani Mo
CHIEF SCIENTIFIC OFFICER
Führungsperson
|
7.347
-5.1%
44,20
324.717 USD
|
7.347
-5.1%
|
44,20
|
324.717 USD
|
|
|
2025-01-21 |
2025-01-16 |
V
Verkauf
|
Myles Edward H
COO & CFO
Führungsperson
|
12.539
-7.8%
44,20
554.189 USD
|
12.539
-7.8%
|
44,20
|
554.189 USD
|
|
|
2025-01-21 |
2025-01-16 |
V
Verkauf
|
Sacco Tracey
Chief Commercial Officer
Führungsperson
|
3.890
-7.9%
44,20
171.927 USD
|
3.890
-7.9%
|
44,20
|
171.927 USD
|
|
|
2025-01-21 |
2025-01-16 |
V
Verkauf
|
Parlavecchio Caryn
CHRO
Führungsperson
|
6.434
-4.2%
44,20
284.365 USD
|
6.434
-4.2%
|
44,20
|
284.365 USD
|
|
|
2025-01-21 |
2025-01-16 |
V
Verkauf
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Führungsperson
|
5.655
-7.8%
44,20
249.935 USD
|
5.655
-7.8%
|
44,20
|
249.935 USD
|
|
|
2025-01-21 |
2025-01-16 |
V
Verkauf
|
Backstrom Jay T.
CHIEF EXECUTIVE OFFICER
Geschäftsführender Verwaltungsratsmitglied
|
22.308
-6.3%
44,20
985.951 USD
|
22.308
-6.3%
|
44,20
|
985.951 USD
|
|
|
2024-12-12 |
2024-12-10 |
V
Verkauf
|
Invus Public Equities, L.P.
Large shareholder
|
1.600.000
-14.7%
41,65
66.640.000 USD
|
1.600.000
-14.7%
|
41,65
|
66.640.000 USD
|
|
|
2024-11-27 |
2024-11-25 |
V
Verkauf
|
Invus Public Equities, L.P.
Large shareholder
|
149
-0.0%
40,98
6.106 USD
|
149
-0.0%
|
40,98
|
6.106 USD
|
|
|
2024-11-27 |
2024-11-25 |
V
Verkauf
|
Invus Public Equities, L.P.
Large shareholder
|
30.683
-0.3%
40,14
1.231.585 USD
|
30.683
-0.3%
|
40,14
|
1.231.585 USD
|
|
|
2024-11-27 |
2024-11-25 |
V
Verkauf
|
Invus Public Equities, L.P.
Large shareholder
|
126.442
-1.1%
39,51
4.995.774 USD
|
126.442
-1.1%
|
39,51
|
4.995.774 USD
|
|
|
2024-11-27 |
2024-11-25 |
V
Verkauf
|
Invus Public Equities, L.P.
Large shareholder
|
43.887
-0.4%
38,43
1.686.670 USD
|
43.887
-0.4%
|
38,43
|
1.686.670 USD
|
|
|
2024-11-27 |
2024-11-25 |
V
Verkauf
|
Invus Public Equities, L.P.
Large shareholder
|
208.272
-1.8%
37,63
7.837.504 USD
|
208.272
-1.8%
|
37,63
|
7.837.504 USD
|
|
|
2024-11-26 |
2024-11-25 |
GV
Geplanter Verkauf
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Führungsperson
|
200
-0.3%
40,72
8.144 USD
|
200
-0.3%
|
40,72
|
8.144 USD
|
|
|
2024-11-26 |
2024-11-25 |
GV
Geplanter Verkauf
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Führungsperson
|
3.075
-4.0%
39,93
122.780 USD
|
3.075
-4.0%
|
39,93
|
122.780 USD
|
|
|
2024-11-26 |
2024-11-25 |
GV
Geplanter Verkauf
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Führungsperson
|
2.100
-2.7%
39,25
82.434 USD
|
2.100
-2.7%
|
39,25
|
82.434 USD
|
|
|
2024-11-26 |
2024-11-25 |
GV
Geplanter Verkauf
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Führungsperson
|
1.000
-1.3%
38,04
38.041 USD
|
1.000
-1.3%
|
38,04
|
38.041 USD
|
|
|
2024-11-26 |
2024-11-22 |
GV
Geplanter Verkauf
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Führungsperson
|
2.145
-2.9%
30,01
64.372 USD
|
2.145
-2.9%
|
30,01
|
64.372 USD
|
|
|
2024-11-13 |
2024-11-11 |
GV
Geplanter Verkauf
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Führungsperson
|
2.105
-2.8%
30,00
63.158 USD
|
2.105
-2.8%
|
30,00
|
63.158 USD
|
|
|
2024-10-10 |
2024-10-08 |
GV
Geplanter Verkauf
|
Myles Edward H
COO & CFO
Führungsperson
|
37.187
-18.8%
34,90
1.297.659 USD
|
37.187
-18.8%
|
34,90
|
1.297.659 USD
|
|
|
2024-10-07 |
2024-10-07 |
GV
Geplanter Verkauf
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Führungsperson
|
39.375
-35.1%
30,06
1.183.652 USD
|
39.375
-35.1%
|
30,06
|
1.183.652 USD
|
|
|
2024-10-07 |
2024-10-07 |
GV
Geplanter Verkauf
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Führungsperson
|
2.552
-2.2%
26,22
66.923 USD
|
2.552
-2.2%
|
26,22
|
66.923 USD
|
|
|
2024-10-07 |
2024-10-07 |
GV
Geplanter Verkauf
|
Marantz Jing L.
CHIEF MEDICAL OFFICER
Führungsperson
|
67.448
-37.0%
25,59
1.725.893 USD
|
67.448
-37.0%
|
25,59
|
1.725.893 USD
|
|
|
2024-10-07 |
2024-10-07 |
GV
Geplanter Verkauf
|
Sacco Tracey
CHIEF COMMERCIAL OFFICER
Führungsperson
|
1.964
-3.8%
26,23
51.516 USD
|
1.964
-3.8%
|
26,23
|
51.516 USD
|
|
|
2024-10-07 |
2024-10-07 |
GV
Geplanter Verkauf
|
Sacco Tracey
CHIEF COMMERCIAL OFFICER
Führungsperson
|
28.036
-35.4%
25,58
717.161 USD
|
28.036
-35.4%
|
25,58
|
717.161 USD
|
|
|
2024-10-07 |
2024-10-07 |
GV
Geplanter Verkauf
|
Myles Edward H
COO & CFO
Führungsperson
|
31.250
-16.2%
29,05
907.813 USD
|
31.250
-16.2%
|
29,05
|
907.813 USD
|
|
|
2024-10-07 |
2024-10-07 |
GV
Geplanter Verkauf
|
Myles Edward H
COO & CFO
Führungsperson
|
25.812
-11.8%
27,27
703.893 USD
|
25.812
-11.8%
|
27,27
|
703.893 USD
|
|
|
2024-10-07 |
2024-10-07 |
GV
Geplanter Verkauf
|
Myles Edward H
COO & CFO
Führungsperson
|
37.206
-14.6%
26,83
998.237 USD
|
37.206
-14.6%
|
26,83
|
998.237 USD
|
|
|
2024-10-07 |
2024-10-07 |
GV
Geplanter Verkauf
|
Myles Edward H
COO & CFO
Führungsperson
|
111.972
-30.5%
25,61
2.867.603 USD
|
111.972
-30.5%
|
25,61
|
2.867.603 USD
|
|
|
2024-10-07 |
2024-10-07 |
GV
Geplanter Verkauf
|
AKKARAJU SRINIVAS
Nicht geschäftsführender Verwaltungsratsmitglied
|
155.713
-2.7%
32,50
5.060.673 USD
|
155.713
-2.7%
|
32,50
|
5.060.673 USD
|
|
|
2024-10-07 |
2024-10-07 |
GV
Geplanter Verkauf
|
AKKARAJU SRINIVAS
Nicht geschäftsführender Verwaltungsratsmitglied
|
510.000
-8.1%
30,00
15.300.000 USD
|
510.000
-8.1%
|
30,00
|
15.300.000 USD
|
|
|
2024-10-07 |
2024-10-07 |
GV
Geplanter Verkauf
|
AKKARAJU SRINIVAS
Nicht geschäftsführender Verwaltungsratsmitglied
|
510.000
-7.5%
27,50
14.025.000 USD
|
510.000
-7.5%
|
27,50
|
14.025.000 USD
|
|
|
2024-09-19 |
2024-09-16 |
V
Verkauf
|
Qatanani Mo
CHIEF SCIENTIFIC OFFICER
Führungsperson
|
1.936
-1.3%
8,58
16.611 USD
|
1.936
-1.3%
|
8,58
|
16.611 USD
|
|
|
2024-08-19 |
2024-08-16 |
V
Verkauf
|
Parlavecchio Caryn
CHRO
Führungsperson
|
1.451
-0.9%
9,33
13.538 USD
|
1.451
-0.9%
|
9,33
|
13.538 USD
|
|
|
2024-06-18 |
2024-06-17 |
V
Verkauf
|
Myles Edward H
COO & CFO
Führungsperson
|
9.458
-4.5%
8,98
84.978 USD
|
9.458
-4.5%
|
8,98
|
84.978 USD
|
|
|
2024-06-18 |
2024-06-17 |
V
Verkauf
|
Qatanani Mo
CHIEF SCIENTIFIC OFFICER
Führungsperson
|
2.315
-1.6%
8,99
20.800 USD
|
2.315
-1.6%
|
8,99
|
20.800 USD
|
|
|
2024-06-18 |
2024-06-17 |
V
Verkauf
|
Parlavecchio Caryn
CHRO
Führungsperson
|
4.305
-2.7%
8,98
38.680 USD
|
4.305
-2.7%
|
8,98
|
38.680 USD
|
|
|
2024-06-18 |
2024-06-17 |
V
Verkauf
|
Ho Junlin
GENERAL COUNSEL
Führungsperson
|
4.695
-2.2%
8,98
42.183 USD
|
4.695
-2.2%
|
8,98
|
42.183 USD
|
|
|
2024-02-21 |
2024-02-16 |
V
Verkauf
|
Myles Edward H
COO & CFO
Führungsperson
|
4.744
-2.2%
15,74
74.686 USD
|
4.744
-2.2%
|
15,74
|
74.686 USD
|
|
|
2024-02-20 |
2024-02-16 |
V
Verkauf
|
Parlavecchio Caryn
CHRO
Führungsperson
|
3.751
-2.3%
15,74
59.053 USD
|
3.751
-2.3%
|
15,74
|
59.053 USD
|
|
|
2024-02-20 |
2024-02-16 |
V
Verkauf
|
Ho Junlin
GENERAL COUNSEL
Führungsperson
|
3.489
-1.6%
15,74
54.928 USD
|
3.489
-1.6%
|
15,74
|
54.928 USD
|
|
|
2024-02-20 |
2024-02-16 |
V
Verkauf
|
Qatanani Mo
CHIEF SCIENTIFIC OFFICER
Führungsperson
|
2.512
-1.7%
15,74
39.547 USD
|
2.512
-1.7%
|
15,74
|
39.547 USD
|
|
|
2024-02-20 |
2024-02-16 |
V
Verkauf
|
Backstrom Jay T.
CHIEF EXECUTIVE OFFICER
Geschäftsführender Verwaltungsratsmitglied
|
11.614
-3.2%
15,74
182.842 USD
|
11.614
-3.2%
|
15,74
|
182.842 USD
|
|
|
2024-01-18 |
2024-01-16 |
V
Verkauf
|
Ho Junlin
GENERAL COUNSEL
Führungsperson
|
4.186
-2.6%
15,93
66.677 USD
|
4.186
-2.6%
|
15,93
|
66.677 USD
|
|
|
2024-01-18 |
2024-01-16 |
V
Verkauf
|
Qatanani Mo
SVP AND HEAD OF RESEARCH
Führungsperson
|
2.002
-2.5%
15,93
31.889 USD
|
2.002
-2.5%
|
15,93
|
31.889 USD
|
|
|
2024-01-18 |
2024-01-16 |
V
Verkauf
|
Parlavecchio Caryn
CHRO
Führungsperson
|
2.849
-2.4%
15,93
45.381 USD
|
2.849
-2.4%
|
15,93
|
45.381 USD
|
|
|
2024-01-18 |
2024-01-16 |
V
Verkauf
|
Myles Edward H
COO & CFO
Führungsperson
|
6.634
-3.9%
15,93
105.670 USD
|
6.634
-3.9%
|
15,93
|
105.670 USD
|
|
|
2023-12-29 |
2023-12-29 |
GV
Geplanter Verkauf
|
Myles Edward H
COO & CFO
Führungsperson
|
300
-0.2%
19,51
5.853 USD
|
300
-0.2%
|
19,51
|
5.853 USD
|
|
|
2023-12-29 |
2023-12-29 |
GV
Geplanter Verkauf
|
Myles Edward H
COO & CFO
Führungsperson
|
12.159
-6.7%
18,82
228.780 USD
|
12.159
-6.7%
|
18,82
|
228.780 USD
|
|
|
2023-12-15 |
2023-12-14 |
V
Verkauf
|
Qatanani Mo
SVP AND HEAD OF RESEARCH
Führungsperson
|
24.662
-23.4%
18,18
448.444 USD
|
24.662
-23.4%
|
18,18
|
448.444 USD
|
|
|
2023-12-08 |
2023-12-07 |
GV
Geplanter Verkauf
|
Myles Edward H
COO & CFO
Führungsperson
|
24.914
-12.9%
17,53
436.820 USD
|
24.914
-12.9%
|
17,53
|
436.820 USD
|
|
|
2023-11-03 |
2023-11-02 |
GV
Geplanter Verkauf
|
Myles Edward H
COO & CFO
Führungsperson
|
35.007
-17.2%
12,51
438.039 USD
|
35.007
-17.2%
|
12,51
|
438.039 USD
|
|
|
2023-10-18 |
2023-10-16 |
K
Kauf
|
Samsara BioCapital GP, LLC
Large shareholder
|
2.189.781
+47.6%
6,85
15.000.000 USD
|
2.189.781
+47.6%
|
6,85
|
15.000.000 USD
|
|
|
2023-10-18 |
2023-10-16 |
K
Kauf
|
AKKARAJU SRINIVAS
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
2.189.781
+47.6%
6,85
15.000.000 USD
|
2.189.781
+47.6%
|
6,85
|
15.000.000 USD
|
|
|
2023-10-16 |
2023-10-12 |
K
Kauf
|
Invus Public Equities, L.P.
Large shareholder
|
10.150
+0.1%
8,55
86.736 USD
|
10.150
+0.1%
|
8,55
|
86.736 USD
|
|
|
2023-10-16 |
2023-10-12 |
K
Kauf
|
Invus Public Equities, L.P.
Large shareholder
|
2.189.781
+24.2%
6,85
15.000.000 USD
|
2.189.781
+24.2%
|
6,85
|
15.000.000 USD
|
|
|
2023-09-20 |
2023-09-18 |
V
Verkauf
|
Qatanani Mo
SVP AND HEAD OF RESEARCH
Führungsperson
|
1.945
-2.0%
6,34
12.331 USD
|
1.945
-2.0%
|
6,34
|
12.331 USD
|
|
|
2023-08-18 |
2023-08-16 |
V
Verkauf
|
Parlavecchio Caryn
CHRO
Führungsperson
|
1.353
-1.1%
6,83
9.241 USD
|
1.353
-1.1%
|
6,83
|
9.241 USD
|
|
|
2023-05-02 |
2023-04-28 |
K
Kauf
|
Invus Public Equities, L.P.
Large shareholder
|
31.557
+0.3%
6,43
202.845 USD
|
31.557
+0.3%
|
6,43
|
202.845 USD
|
|
|
2023-01-11 |
2023-01-09 |
V
Verkauf
|
Invus Public Equities, L.P.
Large shareholder
|
1.094
-0.0%
9,48
10.373 USD
|
1.094
-0.0%
|
9,48
|
10.373 USD
|
|
|
2023-01-09 |
2023-01-05 |
K
Kauf
|
Invus Public Equities, L.P.
Large shareholder
|
48.774
+0.5%
9,33
455.091 USD
|
48.774
+0.5%
|
9,33
|
455.091 USD
|
|
